Johnson & Johnson diskutieren
Johnson & Johnson
WKN: 853260 / Symbol: JNJ / Name: Johnson & Johnson / Aktie / Pharmazeutika / Large Cap /
152,00 €
1,41 %
Buy Johnson & Johnson
Buy Johnson & Johnson
Buy with target price 126.48
Buy Johnson & Johnson
Buy Johnson & Johnson
Buy Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Raymond James from $181.00 to $184.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Raymond James from $184.00 to $179.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Raymond James from $179.00 to $172.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Arrowhead Pharmaceuticals Inc. diskutieren